Anna Graipe
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Cardiac Health and Mental Health 2
- Antiplatelet Therapy and Cardiovascular Diseases 2
- Acute Myocardial Infarction Research 2
- Atrial Fibrillation Management and Outcomes 2
- Heart Failure Treatment and Management 2
-
- Acute Ischemic Stroke Management 3
- Co-authors
- Thomas Mooe (10 shared papers)Anders Ulvenstam (5 shared papers)Lars Söderström (4 shared papers)Fredrik Björklund (3 shared papers)Daniel Huber (3 shared papers)Tomas Jernberg (1 shared paper)
- Journals
- Scientific Reports (4 papers)The Lancet (2 papers)Cerebrovascular Diseases (1 paper)Journal of the American Heart Association (1 paper)International Journal of Cardiology (1 paper)
- Partner nations
- Sweden
In The Last Decade
Anna Graipe
12 papers receiving 2.8k citations
Anna Graipe's Hit Papers
Peers
Comparison fields: 5 of 73
- Endocrinology, Diabetes and Metabolism 2.2k
- Pharmacology 313
- Nephrology 121
- Cardiology and Cardiovascular Medicine 342
- Surgery 578
Countries citing papers authored by Anna Graipe
This map shows the geographic impact of Anna Graipe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Graipe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Graipe more than expected).
Fields of papers citing papers by Anna Graipe
This network shows the impact of papers produced by Anna Graipe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Graipe. The network helps show where Anna Graipe may publish in the future.
Co-authors
The 6 scholars most cited alongside Anna Graipe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2307 |
| 2 | Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 492 |
| 3 | 2014 | 17 | |
| 4 | 2014 | 15 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 13 | |
| 7 | 2015 | 11 | |
| 8 | 2021 | 9 | |
| 9 | 2014 | 8 | |
| 10 | 2018 | 4 | |
| 11 | 2014 | 4 | |
| 12 | 2021 | 3 |
About Anna Graipe
Anna Graipe is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology, Endocrinology, Diabetes and Metabolism, Internal Medicine and Public Health, Environmental and Occupational Health, having authored 12 papers that have together received 2.9k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (3 papers), Cardiac Health and Mental Health (2 papers), Diabetes Treatment and Management (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Acute Myocardial Infarction Research (2 papers), Atrial Fibrillation Management and Outcomes (2 papers), Heart Failure Treatment and Management (2 papers) and Venous Thromboembolism Diagnosis and Management (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.2k citations), Pharmacology (313 citations), Nephrology (121 citations), Cardiology and Cardiovascular Medicine (342 citations) and Surgery (578 citations). Anna Graipe has collaborated with scholars based in Sweden. Frequent co-authors include Thomas Mooe, Anders Ulvenstam, Lars Söderström, Fredrik Björklund, Daniel Huber and Tomas Jernberg. Their work appears in journals such as Scientific Reports, The Lancet, Cerebrovascular Diseases, Journal of the American Heart Association and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.